Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy.

导出 LinkOut

翻译打印收藏纠错

作者： Bao,Li ^[1] ; Haoran,Niu ^[1] ; Xiaoyun,Zhao ^[2] ; Xiaoyu,Huang ^[1] ; Yu,Ding ^[1] ; Ke,Dang ^[1] ; Tianzhi,Yang ^[3] ; Yongfeng,Chen ^[1] ; Jizhuang,Ma ^[1] ; Xiaohong,Liu ^[1] ; Keda,Zhang ^[4] ; Huichao,Xie ^[4] ; Pingtian,Ding ^[4]

作者单位： School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China. ^[1] School of Life Science and Biopharmaceutics Shenyang Pharmaceutical University Shenyang 110016, China. ^[2] Department of Basic Pharmaceutical Sciences School of Pharmacy Husson University Bangor, ME 04401, USA. ^[3] College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China. ^[4]

关键词 Anti-angiogenesis Hypoxia inducible factor (HIF)-1 protein Nanoparticles Phenethyl isothiocyanate (PEITC)Tumor apoptosis VEGF siRNA

DOI 10.1016/j.ajps.2024.100891

PMID 38584690

发布时间 2024-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Asian journal of pharmaceutical sciences

2024年19卷2期

100891页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy.

Asian journal of pharmaceutical sciences

相似文献

Asian journal of pharmaceutical sciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy.

Asian journal of pharmaceutical sciences

相似文献

Asian journal of pharmaceutical sciences

相关期刊

检索历史清除